Here's Why Medtronic (MDT) is a Strong Value Stock

Medtronic (MDT) is highlighted as a strong value stock, despite its Zacks Rank #3 (Hold), due to a robust VGM Score of B and a Value Style Score of B, underpinned by a forward P/E of 17.05. The company's fiscal 2026 earnings outlook has improved, with 11 analysts raising estimates in the past 60 days, increasing the Zacks Consensus Estimate by $0.07 to $5.62 per share. These positive revisions and an average earnings surprise of +2.2% position MDT as a compelling consideration for value-focused investors.

Analysis

Medtronic (MDT) presents a compelling case for value-oriented investors despite its neutral Zacks #3 (Hold) rating. The stock's attractiveness is supported by a 'B' grade for both its Value and overall VGM Style Scores, anchored by a forward P/E ratio of 17.05. More significant is the positive shift in its forward outlook, with 11 analysts revising their fiscal 2026 earnings estimates upward over the last 60 days. This has lifted the Zacks Consensus Estimate for that period by $0.07 to $5.62 per share. This improving sentiment is further bolstered by a consistent track record of performance, evidenced by an average positive earnings surprise of 2.2%. The combination of these fundamental factors—an attractive valuation, positive earnings estimate revisions, and historical earnings beats—positions MDT as a noteworthy candidate for portfolios focused on value.

Key Decisions for Investors

• Value-oriented investors may find MDT's valuation attractive, supported by its 'B' Value Score and a forward P/E of 17.05, suggesting it could be a candidate for inclusion on a watchlist.
• Monitor the trend in analyst earnings revisions for fiscal 2026, as continued upward momentum could serve as a key positive catalyst for the stock.
• Despite the favorable value metrics and positive estimate revisions, the neutral Zacks #3 'Hold' rank warrants a balanced approach, suggesting investors should consider this mixed signal before committing significant capital.